AngioDynamics Q1 adjusted EPS $-0.04
ANGO•AngioDynamics reported Q1 adjusted EPS of -$0.04 and sales of $80.9 million, compared with an IBES estimate of $80.5 million. It forecast fiscal-year sales of $336 million to $341 million and adjusted EPS of -$0.29 to -$0.24.
1. Quarterly results and outlook
AngioDynamics reported Q1 net income of -$7.1 million and adjusted net income of -$1.8 million. The company forecast fiscal-year sales of $336 million to $341 million and adjusted EPS of -$0.29 to -$0.24.
